Definitive Contract HHSF223201610046C
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $720,000.00 firm fixed price contract to The Regents of the University of Colorado, doing business as the University of Colorado Denver, to conduct a study investigating the combination of physical activity and heart rate using actigraphy as an endpoint to facilitate pediatric pulmonary arterial hypertension trials and drug development. The contract was awarded on August 22, 2019 and has a completion date of...
- This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The $609,101 contract is for biomedical research and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public research university that frequently...
- This is a $178,009.63 Firm Fixed Price definitive contract awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, for lung cancer research. The contract has an ultimate completion date of August 31, 2023 and does not have a set-aside designation. The University of Colorado-Denver is a major public research university that frequently receives federal funding through...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for $370,032.00 and provides physical medical and rehabilitation research services. The contract has an ultimate completion date of January 31, 2026. The University of Colorado-Denver is a prominent public research university and state government entity that has extensive experience...
- The University of Colorado Denver, known as the University of Colorado-Denver, was awarded a $11,755,165.47 cost-reimbursement contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, which runs through February 2026, does not have a set-aside designation. The contract is a definitive contract for the university to provide a variety of services and conduct research across disciplines including medicine,...
- This federal contract award, valued at $506,725.61, was issued by the National Institute of Child Health and Human Development (NICHD) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract, which does not have a set-aside designation, is for the provision of Clinical Center for Translational Neuroscience (CCTN) Female Sites services. The University of Colorado-Denver holds an Indefinite Delivery Contract (IDV) with NICHD for these...
- This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to the University of Colorado-Denver to provide tuition and fees. The contract has a ceiling value of $88,457.82 and a period of performance through December 31, 2016. The University of Colorado-Denver is a major public research university that frequently receives federal funding through contracts and grants to support its research, education, and...
- This federal contract award is for a Definitive Contract with a Ceiling Value of $570,344,932.37, awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for "BIOMEDICAL (BASIC)" services and has an Ultimate Completion Date of December 31, 2011. The University of Colorado-Denver is a major public research university that...
- This federal contract award is for a research study being conducted by Dr. Kohrt, which is grant-funded. The action is to de-obligate unused funds from this research study, which had a ceiling value of $23,693.09 and was awarded on September 1, 2022. The prime contractor is The Regents of the University of Colorado, doing business as the University of Colorado-Denver, a prominent public research university that frequently receives federal contracts and grants. The funding agency is the...
- The National Heart Lung and Blood Institute, a civilian federal agency, awarded a $70,404.58 firm fixed-price purchase order contract to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for the development, performance, and validation of enzyme and protein assays for PPA2. There was no set-aside designation for this award. The University of Colorado-Denver is a public research university that conducts fundamental research and...
This federal contract was awarded by the Food and Drug Administration (FDA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for a study titled "Pediatric Pulmonary Hypertension Actigraphy Endpoint Clinical Study and Data Submission" with a ceiling value of $218,721.00. It is a definitive, firm fixed-price contract with a completion date of March 30, 2019. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public research university that regularly receives federal contracts and grants to support its research, education, and public service missions. The university has a long history of conducting clinical trials and medical research on behalf of federal agencies like the NIH and VA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | ($77k) | 2/4/22 | |
| 3 | Other Administrative Action | $0 | 3/18/19 | |
| 2 | Additional Work (new agreement, FAR part 6 applies) | $43.4k | 7/27/17 | |
| 1 | Exercise an Option | $106.3k | 7/12/17 | |
| Not listed | Not listed | $146.0k | 6/22/16 |